Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Open in API
Filings indexed 985 across all filing types
Latest filing 2017-03-02 Annual Report
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2016
2017-03-02 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 2, 2017, by OvaScience, Inc. It announces the company's financial results for the quarter and year ended December 31, 2016. The text explicitly states that the full text of the press release is furnished as an exhibit and that the information is not filed for purposes of Section 18 of the Exchange Act. The document is short (3426 characters) and primarily serves as an announcement of the earnings release rather than containing the financial results itself. According to the rules, such announcements are classified as Earnings Release (ER) if they contain key highlights only, but since this is a Form 8-K announcing the earnings results with a press release attached, it fits best as an Earnings Release (ER).
2017-03-02 English
ORBIS INVESTMENT MANAGEMENT LIMITED
Major Shareholding Notification
2017-02-14 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-02-14 English
13G AMENDMENT
Major Shareholding Notification
2017-02-13 English
ADAGE CAPITAL PARTNERS GP, L.L.C.
Major Shareholding Notification
2017-02-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.